• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON & CO. (SPARKS) BD BBL¿ THIOGLYCOLLATE MEDIUM, ENRICHED WITH VITAMIN K1 AND HEMIN; CULTURE MEDIA, NON-SELECTIVE AND NON-DIFFERENTIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON & CO. (SPARKS) BD BBL¿ THIOGLYCOLLATE MEDIUM, ENRICHED WITH VITAMIN K1 AND HEMIN; CULTURE MEDIA, NON-SELECTIVE AND NON-DIFFERENTIAL Back to Search Results
Model Number 221788
Device Problem Contamination /Decontamination Problem (2895)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 05/30/2023
Event Type  malfunction  
Event Description
It was reported that while using bd bbl¿ thioglycollate medium, enriched with vitamin k1 and hemin there was biological contamination.This occurred on twenty tubes.No erroneous results were passed on to the clinician.There was no patient impact.The following information was provided by the initial reporter: "the broth is turbid and gram-negative rods were detected in the gram preparation".
 
Manufacturer Narrative
H.3.A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Manufacturer Narrative
H.6.Investigation summary: this complaint can be confirmed by the trend.The complaint history was reviewed, and two other complaints have been taken on this batch for contamination.Retention samples from batch 3011172 (10 tubes) were available for inspection.No contamination or turbidity was observed in 10/10 retention samples.For investigation, two retention tubes went into incubation.One tube was incubated in the 20-25 degrees celsius, and the other tube was placed in the 33¿37-degree celsius incubator.At 7 days incubation, no microbial growth or turbidity was observed in 2/2 incubated tubes.One photo was received to assist with the investigation.The photo shows two tubes, one from batch 3011172 and one tube from batch 2251073.The tube from batch 3011172 does appear to be hazy in clarity.No returns were received to assist with the investigation.The cause of the hazy media in the photo could not be identified from this investigation.However, bd has identified a complaint trend for hazy media due to the presence of non-viables for this product.A capa (corrective and preventative actions) has been initiated per bd procedures.The capa has completed execution of corrective actions.Bd expects improvement in the observation of hazy media due to non-viables as the capa progresses.Bd will continue to trend complaints for contamination/appearance (turbidity) defects.This complaint can be confirmed by the trend.
 
Event Description
It was reported that while using bd bbl¿ thioglycollate medium, enriched with vitamin k1 and hemin there was biological contamination.This occurred on twenty tubes.No erroneous results were passed on to the clinician.There was no patient impact.The following information was provided by the initial reporter: "the broth is turbid and gram-negative rods were detected in the gram preparation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD BBL¿ THIOGLYCOLLATE MEDIUM, ENRICHED WITH VITAMIN K1 AND HEMIN
Type of Device
CULTURE MEDIA, NON-SELECTIVE AND NON-DIFFERENTIAL
Manufacturer (Section D)
BECTON, DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
Manufacturer (Section G)
BECTON, DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
Manufacturer Contact
phillip emmert
5859 farinon drive
san antonio, TX 78249
8448235433
MDR Report Key17148121
MDR Text Key317757080
Report Number1119779-2023-00672
Device Sequence Number1
Product Code JSG
UDI-Device Identifier30382902217887
UDI-Public30382902217887
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
K803023
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 10/27/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date01/09/2024
Device Model Number221788
Device Catalogue Number221788
Device Lot Number3011172
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/30/2023
Initial Date FDA Received06/16/2023
Supplement Dates Manufacturer Received10/27/2023
Supplement Dates FDA Received11/13/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/11/2023
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-